Grants for Independent school districts - Health
Explore 2,582 grant opportunities
Application Deadline
Dec 9, 2024
Date Added
Feb 8, 2022
This funding opportunity supports collaborative research projects aimed at addressing brain and nervous system disorders in low- and middle-income countries, focusing on building sustainable research capacity and improving neuro-health outcomes.
Application Deadline
Jul 1, 2024
Date Added
Apr 5, 2022
The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Phased Innovation (R61/R33) grant applications to support development of clinical trials to treat critical and co-occurring health conditions in individuals with Down syndrome. The proposed research aims should be milestone-driven. The total project period for an application submitted in response to this FOA may not exceed five years. This FOA provides support for up to two years (R61 phase) for preliminary/developmental/planning studies, followed by possible transition to clinical trial support (R33) of up to three years, although the total duration of the award may not exceed five years. This FOA requires measurable R61 milestones.
Application Deadline
Jun 4, 2024
Date Added
Mar 20, 2024
Every year more than 795,000 people in the United States have a stroke. On average, thats 1 person every 40 seconds. On average, 1 American dies from a stroke every 3 minutes and 14 seconds. Approximately 9.4 million American adults 20 years of age self-report having had a stroke. These data are disturbing, more so as 80% of strokes are preventable.Prevention begins with implementing equity-focused systems and interventions that assist populations at the highest risk in detecting and managing cardiovascular disease (CVD) and mitigating systemic social conditions that contribute to the increased prevalence of CVD. Roughly 1 in 10 (9.9% 28.6 million) adults in the US have at least 1 type of CVD, including coronary heart disease, heart failure, or stroke. This number excludes hypertension, a risk factor for and cause of CVD but not a type of CVD. However, hypertension or high blood pressure is a critical risk factor for stroke. An estimated 120 million American adults (48.1%) have it, most (3 in 4) dont have it controlled, and 1 in 5 adults is unaware they have hypertension. High blood cholesterol, smoking, obesity, and diabetes also contribute to stroke risk.Heart disease, stroke, and their modifiable risk factors are experienced disproportionately throughout the US population based on race and ethnicity, social factors, and geography. Non-Hispanic Black Americans have a higher prevalence and highest death rate from stroke than any other racial group. While non-Hispanic Blacks had the highest age-adjusted stroke death among all races and ethnicities (59.6 per 100,000) in 2021, the age-adjusted stroke death rate for individuals across the board increased from 38.8 per 100,000 in 2020 to 41.1 per 100,000 in 2021. Stroke deaths also increased in southern states, where populations at a higher risk, specifically communities of color, exist. These numbers highlight the critical need to improve access to quality care for those at the highest risk of stroke and for stroke patients.In 2001, Congress provided funding to CDC to establish the Paul Coverdell National Acute Stroke Registry, named after the late US Senator Paul Coverdell of Georgia, who suffered a fatal stroke in 2000 while serving in Congress. In 2012, as the program expanded, the name changed to the Paul Coverdell National Acute Stroke Program. The aim has been to support the implementation of comprehensive stroke systems for individuals at the highest risk of stroke and for stroke patients across the continuum of care from the onset of stroke symptoms through rehabilitation and recovery.This new iteration of Coverdell supports state stroke systems in partnerships with learning collaboratives or coalitions to improve state-level stroke care for those at the highest risk. Recipients will be required to execute a dual approach to addressing stroke in the coordinated systems of care and the implementation of prevention activities in community settings. Recipients will continue their collection and analysis of in-hospital stroke data for those who have experienced a stroke while adding a deep focus on understanding and mitigating the stroke risks among individuals in their communities, also ensuring post-discharge follow-up in either rehabilitation facilities or other community-supportive recovery services.This NOFO requires Coverdell recipients to integrate their work with CDCs other funded programs in states where they exist to mitigate systemic inequities and reduce the prevalence of CVD and hypertension so that another person doesnt die from a stroke every 3 minutes and 14 seconds.
Application Deadline
Mar 18, 2025
Date Added
Aug 16, 2024
This funding opportunity provides $4 million to organizations that can strengthen public health systems and enhance health security in Mali, particularly in challenging and insecure areas.
Application Deadline
May 7, 2024
Date Added
Apr 23, 2020
The purpose of the NIH Independent Scientist Award (K02) is to foster the development of outstanding scientists and enable them to expand their potential to make significant contributions to their field of research. The K02 award provides three to five years of salary support and "protected time" for newly independent scientists who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers. Each independent scientist career award program must be tailored to meet the individual needs of the candidate. This Parent Funding Opportunity Announcement is for basic science experimental studies involving humans, referred to in NOT-OD-18-212 as prospective basic science studies involving human participants. These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should be submitted under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind. Applicants not planning an independent clinical trial or basic experimental study with humans, or proposing to gain research experience in a clinical trial or basic experimental study with humans led by another investigator, must apply to the 'Independent Clinical Trial Not Allowed' companion FOA. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.
Application Deadline
May 2, 2025
Date Added
Aug 9, 2024
This grant provides funding to public health organizations and healthcare providers in the United States to improve prevention, diagnosis, and management of parasitic infections, particularly focusing on Chagas disease, soil-transmitted helminths, and other significant domestic parasitic diseases.
Application Deadline
Aug 13, 2024
Date Added
Apr 30, 2024
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R21 grant mechanism, while RFA-MH-25-185 uses the R01 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.
Application Deadline
Feb 24, 2025
Date Added
Nov 14, 2024
This funding opportunity provides financial support for research projects that explore how policies on tobacco, alcohol, and cannabis use affect health disparities in underserved communities, with a focus on cancer prevention and community collaboration.
Application Deadline
May 9, 2024
Date Added
Mar 31, 2023
The purpose of the The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative Fellows (F32) program is to enhance the research training of promising postdoctorates, early in their postdoctoral training period, who have the potential to become productive investigators in research areas that will advance the goals of the BRAIN Initiative. Applications are encouraged in any research area that is aligned with the BRAIN Initiative, including neuroethics. Applicants are expected to propose research training in an area that clearly complements their predoctoral research. Formal training in analytical tools appropriate for the proposed research is expected to be an integral component of the research training plan. In order to maximize the training potential of the F32 award, this program encourages applications from individuals who have not yet completed their terminal doctoral degree and who expect to do so within 12 months of the application due date. On the application due date, candidates may not have completed more than 12 months of postdoctoral training.
Application Deadline
Oct 15, 2024
Date Added
Jul 19, 2023
The "Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services" grant aims to fund research for developing and testing new care models that effectively combine HIV, addiction, and primary care services to improve health outcomes for individuals at high risk for or living with HIV, Hepatitis, and substance use disorders in the US.
Application Deadline
Nov 5, 2024
Date Added
Jan 12, 2023
This funding opportunity supports researchers in studying and characterizing genetically modified mice that exhibit early life lethality or reduced viability, contributing to our understanding of gene function and its implications for human health.
Application Deadline
Oct 14, 2024
Date Added
Feb 25, 2024
The National Heart, Lung, and Blood Institute (NHLBI) intends to publish a Request for Applications (RFA) seeking applications for a multisite clinical trial that will test a screening approach to identify coronary atherosclerosis and test interventions to reduce the progression of coronary atherosclerosis. There will be only one award for this RFA. The planned RFA will utilize the UG3/UH3 activity code with details provided below. The planned RFA will support a Clinical Coordinating Center (CCC) and will run in parallel with a companion RFA for a collaborating Data Coordinating Center (DCC) application.This RFA will accept only an application that is part of a collaborative pair of applications. The pair must include one application to the CCC UG3/UH3 Notice of Funding Opportunity (NOFO) plus one application to the companion DCC U24 NOFO.Both a CCC application and a collaborating DCC application must be submitted on the same due date for consideration by NHLBI. CCC (UG3/UH3) applications submitted without a collaborative DCC (U24) application will be deemed incomplete and will not proceed to review. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The planned RFAs are expected to be published in Summer 2024 with an expected application due date in Fall 2024.
Application Deadline
Jun 5, 2024
Date Added
Jan 13, 2023
Reissue of RFA-MH-20-401.This Funding Opportunity Announcement (FOA) supports pilot work for subsequent studies testing the effectiveness of strategies to deliver evidence-based mental health services, treatment interventions, and/or preventive interventions (EBPs) in low-resource mental health specialty and non-specialty settings within the United States. The FOA targets settings where EBPs are not currently delivered or delivered with fidelity, such that there are disparities in mental health and related functional outcomes (e.g., employment, educational attainment, stable housing, integration in the community, treatment of comorbid substance use disorders, etc.) for the population(s) served. Implementation strategies should identify and use innovative approaches to remediate barriers to provision, receipt, and/or benefit from EBPs and generate new information about factors integral to achieving equity in mental health outcomes for underserved populations.
Application Deadline
Jan 27, 2025
Date Added
Jul 15, 2024
This funding opportunity supports organizations in rural areas to improve healthcare access and services tailored to local needs, focusing on collaboration among multiple healthcare providers.
Application Deadline
Sep 25, 2025
Date Added
Jul 7, 2022
This grant provides funding for large-scale, collaborative research projects that explore complex questions related to aging, requiring a multidisciplinary team and integration of various components across institutions.
Application Deadline
Nov 7, 2024
Date Added
Nov 21, 2022
This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. This FOA will use the NIH Phased Innovation Award (R61/R33) mechanism to provide up to 2 years of R61 support for initial developmental activities and up to 3 years of R33 support for expanded activities. Through this award, investigators will develop a sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.
Application Deadline
Jul 11, 2024
Date Added
Jun 7, 2024
The Minnesota Housing, in collaboration with Greater Minnesota Housing Fund (GMHF), is launching the Single Family RFP through its Community Homeownership Impact Fund. This initiative is designed to expand and preserve affordable homeownership opportunities across all counties in Minnesota. The programβs mission aligns closely with the foundationβs broader vision: ensuring that every Minnesotan has access to safe, affordable, and sustainable housing. By focusing on single-family, owner-occupied homes, this funding opportunity aims to address both supply and quality gaps, particularly in underserved and economically marginalized communities. Through multiple financing mechanismsβgrants, deferred loans, housing infrastructure bonds, and interim loansβthe program seeks to foster community stability, economic inclusion, and equitable pathways to homeownership. The programβs primary beneficiaries are low- to moderate-income households, with a targeted emphasis on households of color, immigrant households, and those including people with disabilities. This focus reflects GMHFβs commitment to applying a racial and economic equity lens to homeownership initiatives, aiming to reduce historic disparities in property ownership and wealth accumulation. Targeted investments will support both the creation of new affordable housing units and the rehabilitation of existing homes, ensuring that communities not only gain new housing stock but also preserve their existing neighborhoods. Special priority will be given to applicants leveraging cross-sector collaborationsβparticularly in health and housingβto improve overall community well-being. Strategically, the program prioritizes projects that deliver tangible, lasting impact. Priority activities include acquisition, rehabilitation, and resale of existing properties; new construction of single-family homes; and stand-alone affordability gap assistance. Additional emphasis is placed on projects that advance Tribal housing initiatives, ensuring that Tribal Nations and communities have equitable access to homeownership opportunities. By offering flexible funding typesβincluding forgivable loans and deferred downpayment assistanceβthe program allows local governments, nonprofits, Tribal entities, and developers to structure their projects to meet community-specific needs and financial realities. Expected outcomes are centered on measurable, high-impact results. Awarded projects must lead to the creation or preservation of affordable, owner-occupied homes with no more than four units, ensuring at least one unit is owner-occupied. The program anticipates that these efforts will expand the affordable housing inventory, increase homeownership rates among underrepresented populations, and stabilize neighborhoods. Success metrics will include the number of homes developed or rehabilitated, the number of households served, demographic diversity among beneficiaries, and the degree to which affordability thresholds are met and maintained. Additionally, the program seeks to generate long-term community benefits such as improved health outcomes, greater neighborhood investment, and increased intergenerational wealth. The foundationβs strategic priorities and theory of change rest on the belief that stable, affordable homeownership is a critical lever for advancing economic mobility and community resilience. By combining capital investment with equitable housing strategies, the program aims to dismantle systemic barriers to homeownership and create conditions for sustained prosperity. Through partnerships with municipalities, Tribal governments, nonprofits, and developers, Minnesota Housing and GMHF are fostering a collaborative ecosystem that ensures funding leads to meaningful, measurable, and community-driven change. This initiative is not merely about building housesβitβs about empowering people, strengthening communities, and reshaping the housing landscape in Minnesota for a more inclusive future.
Application Deadline
Nov 19, 2024
Date Added
Aug 21, 2023
This grant provides financial support and mentorship for outstanding graduate students in the U.S. who are pursuing a PhD in cancer research, helping them transition to postdoctoral training and independent research careers.
Application Deadline
Nov 16, 2024
Date Added
Sep 9, 2024
This funding opportunity supports researchers exploring the biological and genetic factors contributing to cancer health disparities among racial and ethnic groups, aiming to generate insights for future studies.
Application Deadline
Jul 31, 2024
Date Added
Jun 11, 2024
Black/African Americans have been disproportionately affected by HIV since the early days of the epidemic and that disparity has deepened over time. Although they represent only 12% of the population, Black/African Americans account for approximately 43% of new HIV diagnosis. This disparity is further exacerbated by the critical shortage of primary care providers trained to provide counseling, HIV testing, prescribe PrEP and HIV care and treatment. This is especially true for the number of providers working in communities most at-risk for HIV. The purpose of the Building Workforce Capacity through Pathways in HIV Residency Training Program (Pathways Program) is to train internal and family medicine residents in HIV treatment and care management with the goal of increasing the number and diversity of HIV providers.